Cancer Immunology Research Impact Factor, Quartile, Indexing, Ranking

Cancer Immunology Research (CIR) is a scholarly journal dedicated to publishing research in the field of Immunology and Microbiology, and Published by American Association for Cancer Research. The Print-ISSN of Cancer Immunology Research is 2326-6066 and its abbreviation is Cancer Immunol Res.

The Publicaiton fees (APC) is $2400.

Cancer Immunology Research publishes outstanding original articles reporting major advances that span the discipline of cancer immunology, from basic investigations of host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and in-depth analysis of late-stage clinical trials. The journal also publishes reviews and opinion pieces of broad significance across the spectrum of cancer immunology research. As the premier resource for disseminating knowledge of immunology to the cancer research community, the journal catalyzes cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes.

Specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and immunologically insightful clinical investigations.

• Journal Website
• PubMed
• Scopus
• SCImago